These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12769627

  • 1. N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review.
    Millan MJ.
    Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):191-213. PubMed ID: 12769627
    [Abstract] [Full Text] [Related]

  • 2. N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.
    Millan MJ.
    Psychopharmacology (Berl); 2005 Apr; 179(1):30-53. PubMed ID: 15761697
    [Abstract] [Full Text] [Related]

  • 3. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
    Bennett S, Gronier B.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):52-9. PubMed ID: 16307739
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.
    Shim SS, Hammonds MD, Kee BS.
    Eur Arch Psychiatry Clin Neurosci; 2008 Feb 19; 258(1):16-27. PubMed ID: 17901997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. d-cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study.
    Cascella NG, Macciardi F, Cavallini C, Smeraldi E.
    J Neural Transm Gen Sect; 1994 Feb 19; 95(2):105-11. PubMed ID: 7865165
    [Abstract] [Full Text] [Related]

  • 8. Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update.
    Chaves C, Marque CR, Trzesniak C, Machado de Sousa JP, Zuardi AW, Crippa JA, Dursun SM, Hallak JE.
    Braz J Med Biol Res; 2009 Nov 19; 42(11):1002-14. PubMed ID: 19855900
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Development of a novel pharmacotherapy targeted at the N-methyl-D-aspartate receptor-D-serine system for schizophrenia].
    Nishikawa T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Nov 19; 30(5-6):201-6. PubMed ID: 21226316
    [Abstract] [Full Text] [Related]

  • 11. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
    Fujihira T, Kanematsu S, Umino A, Yamamoto N, Nishikawa T.
    Neurochem Int; 2007 Nov 19; 51(2-4):233-6. PubMed ID: 17662507
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade.
    Heresco-Levy U.
    Int J Neuropsychopharmacol; 2000 Sep 19; 3(3):243-258. PubMed ID: 11343602
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of striatal dopamine release by glycine transport inhibitors.
    Javitt DC, Hashim A, Sershen H.
    Neuropsychopharmacology; 2005 Apr 19; 30(4):649-56. PubMed ID: 15688094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.